CYTARABINE SYNDROME

CYTARABINE SYNDROME was reported 76 times

CYTARABINE SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthracycline Topoisomerase Inhibitor [EPC] 32 0.0132
1 Nucleoside Metabolic Inhibitor [EPC] 70 0.0003
2 Echinocandin Antifungal [EPC] 2 0.0002
3 Penem Antibacterial [EPC] 5 0.0001
4 BCL-2 Inhibitor [EPC] 8 0.0001
5 Anticholinergic [EPC] 2 0.0001
6 Lipopeptide Antibacterial [EPC] 1 0.0001
7 Azole Antifungal [EPC] 12 0.0001
8 Asparagine-specific Enzyme [EPC] 1 0.0001
9 Topoisomerase Inhibitor [EPC] 4 0.0001
10 Phenothiazine [EPC] 1 0.0000
11 Glycopeptide Antibacterial [EPC] 2 0.0000
12 Nitroimidazole Antimicrobial [EPC] 2 0.0000
13 Osmotic Laxative [EPC] 7 0.0000
14 Thiazide-like Diuretic [EPC] 1 0.0000
15 Serotonin-3 Receptor Antagonist [EPC] 3 0.0000
16 Macrolide Antimicrobial [EPC] 1 0.0000
17 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
18 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
19 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
20 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
21 Corticosteroid [EPC] 13 0.0000
22 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
23 Alkylating Drug [EPC] 2 0.0000
24 Fluoroquinolone Antibacterial [EPC] 1 0.0000
25 Thiazide Diuretic [EPC] 1 0.0000
26 Factor Xa Inhibitor [EPC] 1 0.0000
27 Proton Pump Inhibitor [EPC] 2 0.0000
28 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
29 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000